Rockwell Medical, Inc.RMTINASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+4929.6%
5Y CAGR+608.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+4929.6%/yr
Quarterly compound
5Y CAGR
+608.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
17869.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 424534.08% |
| Q3 2025 | 0.10% |
| Q2 2025 | -12.49% |
| Q1 2025 | 6.10% |
| Q4 2024 | -3.58% |
| Q3 2024 | 6.64% |
| Q2 2024 | -7.67% |
| Q1 2024 | 34.50% |
| Q4 2023 | -5.69% |
| Q3 2023 | -9.93% |
| Q2 2023 | 2.05% |
| Q1 2023 | -9.69% |
| Q4 2022 | 3.34% |
| Q3 2022 | -24.24% |
| Q2 2022 | 24.06% |
| Q1 2022 | -9.81% |
| Q4 2021 | -12.62% |
| Q3 2021 | 5.38% |
| Q2 2021 | -10.89% |
| Q1 2021 | -11.82% |
| Q4 2020 | 23.76% |
| Q3 2020 | 8.69% |
| Q2 2020 | -33.73% |
| Q1 2020 | 12.01% |
| Q4 2019 | 1.67% |
| Q3 2019 | -16.39% |
| Q2 2019 | -17.24% |
| Q1 2019 | 18.01% |
| Q4 2018 | 28.27% |
| Q3 2018 | 8.23% |
| Q2 2018 | 70.80% |
| Q1 2018 | -43.24% |
| Q4 2017 | 22.50% |
| Q3 2017 | -26.75% |
| Q2 2017 | 7.22% |
| Q1 2017 | 0.84% |
| Q4 2016 | 19.32% |
| Q3 2016 | 1.11% |
| Q2 2016 | 0.55% |
| Q1 2016 | -18.11% |